Indian Journal of Palliative Care
Open access journal 
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size Users online: 984  
     Home | About | Feedback | Login 
  Current Issue Back Issues Editorial Board Authors and Reviewers How to Subscribe Advertise with us Contact Us Analgesic Prescription  
  Navigate Here 
 Search
 
  
 Resource Links
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (235 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this Article
   References

 Article Access Statistics
    Viewed496    
    Printed10    
    Emailed0    
    PDF Downloaded43    
    Comments [Add]    

Recommend this journal

 


 
Table of Contents 
EDITORIAL
Year : 2020  |  Volume : 26  |  Issue : 2  |  Page : 157-158

The Indian society for study of pain, cancer pain special interest group guidelines on cancer pain management in adults


Department of Anaesthesiology, Critical Care and Pain, Homi Bhabha National Institute, Tata Memorial Centre, Mumbai, Maharashtra, India

Date of Web Publication6-Jun-2020

Correspondence Address:
Dr. Parmanand Jain
Department of Anaesthesiology, Critical Care and Pain, Homi Bhabha National Institute, Tata Memorial Centre, E Borges Road, Parel, Mumbai - 400 012, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0973-1075.285685

Rights and Permissions



How to cite this article:
Jain P, Thota RS. The Indian society for study of pain, cancer pain special interest group guidelines on cancer pain management in adults. Indian J Palliat Care 2020;26:157-8

How to cite this URL:
Jain P, Thota RS. The Indian society for study of pain, cancer pain special interest group guidelines on cancer pain management in adults. Indian J Palliat Care [serial online] 2020 [cited 2020 Jul 13];26:157-8. Available from: http://www.jpalliativecare.com/text.asp?2020/26/2/157/285685




Pain is one of the most common and disturbing symptoms in cancer despite the availability of resources and awareness across the world. WHO ladder approach of prescribing analgesics was recommended way back in 1986, however the goal of adequate pain relief to all is far from being realized? Hardly 2-5% patients in moderate to severe cancer pain receive strong opioids. NDPS amendment 2014 came in force due to great efforts undertaken by IAPC and lawyer's community through supreme court pressure, to ease out morphine availability for cancer patients in severe pain. Producers of morphine now just require a single license from respective State Drugs Controller unlike previous times involving prolonged steps and multiple licenses of different validation period. However, the exact impact of NDPS amendment on consumption of morphine for cancer pain in India is not been estimated. What we know that even now our opioid consumption is still very low. Tramadol has also been put under NDPS act since April 2018 due its export and rampant use by ISIS terrorists who used to suppress pain and boost energy. This restriction also came as a big blow to our suffering patients. In current scenario neither WHO step 2 or 3 drugs are available to our needy patients easily in rural and district hospitals. An Indian Face to face survey of 836 patients from 4326 screened general population reported a 19.3% prevalence of chronic pain in India.[1] The study found that 72% patients were taking over the counter (OTC) analgesics. Everdingen MHJB conducted two systematic reviews on prevalence of cancer pain: first one in 2007 and next in 2016[2],[3] and did not find much significant difference in the ensuing decade in the prevalence of cancer pain. He included 117 studies (n = 63333) and pain severity (52 studies, n = 32261) reporting the prevalence as 39.3% after curative treatment, 55% during curative treatment, 66.4% in advanced or metastatic or terminal disease. Pain was found moderate to severe in intensity in 38% patients. Despite all initiatives, a decrease in prevalence rates was not achieved and still many general misconceptions exist ranging from “you don't have to have pain anymore” to “opioids will kill you.”[3] A UK cancer registry data of opioid prescribing during last year of life (n = 6080) analysed the extent and duration of strong opioid treatment, suggesting strategies to be put in place for earlier pain assessment and starting strong opioid treatment to improve pain outcomes.[4] Similarly, a survey of patients and physicians across 10 countries in Asia about current practices in cancer pain management (2015) reported many barriers to adequate pain management e.g. inadequate assessment in 49.7%, fear of addiction (67.2%), adverse events (65%), patients’ reluctance to report pain (52.5%), excessive regulations (48%), reluctance to prescribe opioids (42.8%). Opioid use was only confirmed in 53.2% patients. Pain adversely affected daily activities in almost 81.3% patients.[5] This study highlighted the immediate need for better training and continuing medical education of physicians about cancer pain management. Barriers need to be addressed aggressively to win over the crisis of pain.[6] A study also reported the issue of underdosing of opioids in an Indian cancer hospital.[7] Various initiatives were undertaken in last 5 years in India to enhance pain education. Indian Academy of pain medicine (IAPM) under the Indian society for the study of pain (ISSP) flagship started a fellowship in chronic pain through accredited 10 centers in India in 2016. International association for the study of pain (IASP) conducted many pain schools in south east Asia in last 10 years. ISSP has organized young pain physicians one-day pain CME and later a concept of travelling pain school too became popular to disseminate pain knowledge to MBBS students and general physicians. ISSP formed 9 special interest groups (SIGs) to bring up evidence based best practice pain guidelines for Indian pain practitioners. This issue of IJPC includes 7 articles on cancer pain management covering all aspects from diagnosis to palliative care and end of life based on the evidence-based guidelines. I hope these freshly minted articles will prove to be a torchbearer to young pain physicians during their day to day clinical practice.



 
  References Top

1.
Saxena AK, Jain PN, Bhatnagar S. The prevalence of chronic pain among adults in India. Indian J Palliat Care 2018;24:472-7.  Back to cited text no. 1
[PUBMED]  [Full text]  
2.
van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: A systematic review of the past 40 years. Ann Oncol 2007;18:1437-49.  Back to cited text no. 2
    
3.
van den Beuken-van Everdingen MH, Hochstenbach LM, Joosten EA, Tjan-Heijnen VC, Janssen DJ. Update on prevalence of pain in patients with cancer: Systematic review and meta-analysis. J Pain Symptom Manage 2016;51:1070-90.  Back to cited text no. 3
    
4.
Ziegler L, Mulvey M, Blenkinsopp A, Petty D, Bennett MI. Opioid prescribing for patients with cancer in the last year of life: A longitudinal population cohort study. Pain 2016;157:2445-51.  Back to cited text no. 4
    
5.
ACHEON Working Group, Kim YC, Ahn JS, Calimag MM, Chao TC, Ho KY, et al. Current practices in cancer pain management in Asia: A survey of patients and physicians across 10 countries. Cancer Med 2015;4:1196-204.  Back to cited text no. 5
    
6.
Dureja GP, Jain PN, Joshi M, Saxena A, Das G, Ahdal J, et al. Addressing the barriers related with opioid therapy for management of chronic pain in India. Pain Manag 2017;7:311-30.  Back to cited text no. 6
    
7.
Thota RS, Jain P, Bakshi SG, Dhanve CN. Opioid-prescribing Practices in Chronic Cancer Pain in a Tertiary Care Pain Clinic. Indian J Palliat Care 2011;17:222-6.  Back to cited text no. 7
[PUBMED]  [Full text]  




 

Top
Print this article  Email this article
Online since 1st October '05
Published by Wolters Kluwer - Medknow